Phibro Animal Health Corp (PAHC)
NASDAQ:PAHC
Want to see PAHC full AI Analyst Report?
PAHC Stock Chart & Stats
$57.07
-$0.12(-0.58%)
At close: 4:00 PM EST
$57.07
-$0.12(-0.58%)
Day’s Range― - ―
52-Week Range$22.85 - $60.08
Previous CloseN/A
Volume17.41K
Average Volume (3M)413.70K
Market Cap
$1.16B
Enterprise Value$1.98B
Total Cash (Recent Filing)$77.45M
Total Debt (Recent Filing)$787.44M
Price to Earnings (P/E)12.1
Beta0.88
Next Earnings
Sep 02, 2026EPS Estimate
0.71Next Dividend Ex-DateN/A
Dividend Yield1.28%
Share Statistics
EPS (TTM)2.34
Shares Outstanding21,068,682
10 Day Avg. Volume373,325
30 Day Avg. Volume413,700
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)3.62
Price to Sales (P/S)0.80
P/FCF Ratio24.73
Enterprise Value/Market Cap1.71
Enterprise Value/Revenue1.32
Enterprise Value/Gross Profit4.06
Enterprise Value/Ebitda8.43
Forecast
1Y Price Target
$44.00Price Target Upside-22.90% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)3.07
Revenue Forecast (FY)$1.49B
Bulls Say, Bears Say
Bulls Say
Acquisition-driven GrowthRecent product portfolio acquisitions are driving stronger sales and measurable market share gains, supporting revenue expansion across core markets.
Margin Expansion From Product MixFavorable product mix and operating leverage in the Animal Health business have lifted gross and operating margins, improving profitability per unit of sales.
Raised Guidance And Demand For Medicated Feed AdditivesManagement's raised full-year guidance reflects confidence as stronger-than-expected demand for medicated feed additives and opportunities in international markets support additional sales momentum.
Bears Say
Financial And Governance UncertaintyElevated leverage and an ongoing CEO transition increase uncertainty around execution and the company’s capital structure, potentially constraining strategic flexibility.
Margin Pressure From Tariffs And Higher CostsTariff-related inventory costs combined with planned increases in selling and administrative spending are likely to cause modest margin deterioration and compress operating results.
Relative Profitability And Growth LagAnalyst maintains an underperform rating citing lower profitability and slower revenue growth compared with industry peers, which could limit relative shareholder returns.
Phibro Animal Health News
PAHC FAQ
What was Phibro Animal Health Corp’s price range in the past 12 months?
Phibro Animal Health Corp lowest stock price was $22.85 and its highest was $60.08 in the past 12 months.
What is Phibro Animal Health Corp’s market cap?
Phibro Animal Health Corp’s market cap is $1.16B.
When is Phibro Animal Health Corp’s upcoming earnings report date?
Phibro Animal Health Corp’s upcoming earnings report date is Sep 02, 2026 which is in 91 days.
How were Phibro Animal Health Corp’s earnings last quarter?
Phibro Animal Health Corp released its earnings results on May 06, 2026. The company reported $0.76 earnings per share for the quarter, beating the consensus estimate of $0.713 by $0.047.
Is Phibro Animal Health Corp overvalued?
According to Wall Street analysts Phibro Animal Health Corp’s price is currently Overvalued.
Does Phibro Animal Health Corp pay dividends?
Phibro Animal Health Corp pays a Quarterly dividend of $0.12 which represents an annual dividend yield of 1.28%. See more information on Phibro Animal Health Corp dividends here
What is Phibro Animal Health Corp’s EPS estimate?
Phibro Animal Health Corp’s EPS estimate is 0.71.
How many shares outstanding does Phibro Animal Health Corp have?
Phibro Animal Health Corp has 21,068,682 shares outstanding.
What happened to Phibro Animal Health Corp’s price movement after its last earnings report?
Phibro Animal Health Corp reported an EPS of $0.76 in its last earnings report, beating expectations of $0.713. Following the earnings report the stock price went down -26.222%.
Which hedge fund is a major shareholder of Phibro Animal Health Corp?
Currently, no hedge funds are holding shares in PAHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Phibro Animal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$44.00 (-22.90% Downside)
$44.00 (-22.90% Downside)
Blogger Sentiment
Bullish
PAHC Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 24.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.4%
Last 30 Days ▼ 5.9%
Last 30 Days ▼ 5.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
17.57%
12-Months-Change
Fundamentals
Return on Equity
29.49%
Trailing 12-Months
Asset Growth
9.71%
Trailing 12-Months
Company Description
Phibro Animal Health Corp
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.
PAHC Company Deck
PAHC Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicates solid top-line and profitability momentum—10% revenue growth, double-digit adjusted EBITDA and meaningful upgrades to full-year guidance midpoints—alongside strategic initiatives (sustainability platform) and improved liquidity. Offsetting risks include a steep decline in Performance Products, a significant regulatory change in Brazil affecting ~$26M of prior-year sales (potential FY2027 headwind), FX and interest cost pressures, inventory build-up, and geopolitical uncertainty in the Middle East. Overall, the positive operational and financial trends and upgraded guidance outweigh the disclosed challenges.View all PAHC earnings summariesPAHC Stock 12 Month Forecast
Average Price Target
$44.00
▼(-22.90% Downside)
Technical Analysis
Ownership Overview
1.03% Insiders
23.09% Mutual Funds
19.42% Other Institutional Investors
31.02% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---